Inhibitors of the Renin-Angiotensin-Aldosterone System: Recommendations e363Ĥ.3. Other Anti-Ischemic Interventions e363Ĥ.2. Calcium Channel Blockers: Recommendations e362Ĥ.1.2.5. Beta-Adrenergic Blockers: Recommendations e362Ĥ.1.2.4. Analgesic Therapy: Recommendations e361Ĥ.1.2.3. Anti-Ischemic and Analgesic Medications e360Ĥ.1.2.2. Discharge From the ED or Chest Pain Unit: Recommendations e359Ĥ.1.2. CK-MB and Myoglobin Compared With Troponin e359ģ.5.1. Cardiac Biomarkers and the Universal Definition of MI: Recommendations e357ģ.4.4. Demographics and History in Diagnosis and Risk Stratification e354ģ.4. History: Angina Symptoms and Angina Equivalents e354ģ.3.2.2. Rationale for Risk Stratification and Spectrum of Risk: High, Intermediate, and Low e354ģ.3.2.1. Prognosis–Early Risk Stratification: Recommendations e353ģ.3.1. Biomarkers of Myocardial Necrosis e353ģ.3. ED or Outpatient Facility Presentation: Recommendations e352ģ.2.4. Clinical Assessment and Initial Evaluation: Recommendation e350ģ.1.1. Customer Service and Ordering Informationġ.1.Stroke: Vascular and Interventional Neurology.Journal of the American Heart Association (JAHA).Circ: Cardiovascular Quality & Outcomes.Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB).
0 Comments
Leave a Reply. |